Cargando…
Elevated preoperative HMGB1 as predictor of myocardial injury post-percutaneous coronary intervention
In this study, we evaluated the impact of preoperative high mobility group box 1 (HMGB1) on myocardial injury post-percutaneous coronary intervention. We evaluated 302 consecutive patients who underwent percutaneous coronary intervention. They were divided into equal tertiles based on their preopera...
Autores principales: | Jin, Peng, Zhou, Qi, Song, Shujiang, Xu, Jinpeng, Zhang, Minli, Zhu, Ming, Kang, Meili, Shi, Xiangming, Shi, Junting, Lu, Di, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120896/ https://www.ncbi.nlm.nih.gov/pubmed/27861339 http://dx.doi.org/10.1097/MD.0000000000005149 |
Ejemplares similares
-
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020) -
Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020) -
Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial
por: Song, Pil Sang, et al.
Publicado: (2019) -
Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Tunçez, Abdullah, et al.
Publicado: (2017) -
The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023)